Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

3.2%

1 terminated out of 31 trials

Success Rate

94.4%

+7.9% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

41%

7 of 17 completed with results

Key Signals

7 with results94% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (15)
P 1 (3)
P 2 (4)

Trial Status

Completed17
Unknown8
Active Not Recruiting2
Recruiting2
Withdrawn1
Terminated1

Trial Success Rate

94.4%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT02872831Not ApplicableWithdrawn

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle

NCT03499808Phase 2Completed

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

NCT07155954RecruitingPrimary

Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes

NCT02506933Phase 2Active Not Recruiting

Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant

NCT02537548Not ApplicableActive Not RecruitingPrimary

Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma

NCT06913569Not ApplicableRecruitingPrimary

EBUS-TTFB vs EBUS-TBNA for Diagnosing Inadequate Lymph Node Specimens Based on MOSE

NCT04743583CompletedPrimary

Prevalence and Malignant Involvement of Calcified Intrathoracic Lymph Nodes in Patients Undergoing Endosonography

NCT02948907Not ApplicableCompletedPrimary

"Elastography" and "Tissue Harmonic Imaging" for Characterisation of Hilar and Mediastinal Lymph Nodes

NCT05225493Unknown

HIV Indicator Diseases in Hospital and Primary Care

NCT01505868Phase 1Completed

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

NCT04928560UnknownPrimary

Diagnosis of Superficial Lymphadenopathy

NCT02948283Phase 1Completed

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

NCT01720745Terminated

Comparison of "Wet Suction" Technique to Contemporary "Dry Suction" Technique Using a 22 Gauge Needle for EUS FNA

NCT02530515Phase 2Completed

Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia

NCT01002755Phase 2Completed

Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01465425Unknown

Extracolonic Findings on Computed Tomography (CT) Colonography

NCT02592837Not ApplicableCompletedPrimary

EBUS-TBNA vs Flex 19G EBUS-TBNA

NCT03226964Not ApplicableCompleted

Assessment of High Flow Nasal Cannula Oxygenation in EBUS Bronchoscopy

NCT01769248Not ApplicableCompleted

Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle

NCT01563133Not ApplicableUnknown

Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas

Scroll to load more

Research Network

Activity Timeline